Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Arm Holdings plc (ARM)

Verdict history · ARM

Every call Verdix has made on ARM.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

Click any date below to read that write-up

WaitSell· Aug 22, 2026

The prior WAIT hinged on the stock holding above the monthly 50% Fibonacci retracement at $249.60. That level broke decisively with the weekly close at $243.32, turning a cautious pause into an outright bearish signal. The technical breakdown confirmed what four of six voices already saw in the fundamentals: a price that had outrun even an excellent business.

See methodology for how verdicts are produced. Full track record →

The panel’s case against ARM — and where they disagree.

SellLOW confidence

The case against outweighs the case for at today's price.

NASDAQ · Information Technology / Semiconductor IP · 2026-08-22 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Sell

LOW confidence

Why

Six investing frameworks weigh in on ARM after the stock broke below a key technical level at $249.60. Four voices are bearish, citing a 112× forward P/E that prices in flawless execution even as smartphone royalties decelerate and stock-based compensation dilutes true earnings. One lone bull argues the AI pipeline doubling signals an S-curve the market is underestimating.

Level to watch

Key resistance 249.6

+2.6% from 243.32

Next catalyst

Trigger to confirm the breakdown: A weekly close below the EMA50 at $214.44 would signal Stage 4 decline and open a path toward the low analyst target of $125.

The panel's take

Verdict: SELL · Conviction: LOW · Last price: 243.32 · Changed from WAIT

Panel: 1 Bullish · 1 Neutral · 4 Bearish → SELL

What changed since 2026-08-15:

  • Price: 279.44 → 243.32 (-12.93%)
  • Panel: 1 of 7 → 1 of 6 now Bullish — composition also changed: added The Quality Rationalist; removed The Macro Opportunist, The Moat Compounder
  • Trigger: A weekly close above the weekly EMA20 at $263.34 with the MACD histogram turning up, which would confirm the correction is over and break the bearish weekly setup.
  • Verdict: WAIT → SELL

The prior WAIT hinged on the stock holding above the monthly 50% Fibonacci retracement at $249.60. That level broke decisively with the weekly close at $243.32, turning a cautious pause into an outright bearish signal. The technical breakdown confirmed what four of six voices already saw in the fundamentals: a price that had outrun even an excellent business.

The SELL trigger from the prior article — a weekly close below the monthly 50% Fib at $249.60 — fired with the settled weekly close at $243.32, flipping the prior WAIT to SELL. Four of six voices are bearish: The GARP Operator, The Quality Rationalist, and The Intrinsic-Value Modeler see a wonderful business priced for perfection at 112× forward earnings, while The Forensic Skeptic argues the core smartphone royalty stream is decelerating and true cash earnings are inflated by $1.15B in annual SBC. Even The Disruptive-Innovation Seeker's AI bull case cannot offset the valuation risk at this level, and the lone neutral (The Scuttlebutt Growth Investor) concedes the price leaves no room for error.

Key levels

Key levels · ARM

USD · as of 2026-08-22
Analyst consensus 286.79 ▲
R3276.36
+13.6%
R2263.34
+8.2%
R1249.6
+2.6%
S1234.74
−3.5%
S2214.44
−11.9%
S3201.67
−17.1%
NOW
243.32

Analyst consensus target 286.79 USD · range 125–500

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Key support at $234.74 is the weekly 61.8% Fibonacci retracement — the 'golden pocket' where dip-buyers have historically stepped in. Below that, $214.44 is the weekly EMA50 and the structural bull-market floor; a weekly close beneath it would confirm Stage 4 and open the path to $188.75, the historical resistance-turned-support from the monthly chart. Key resistance at $249.60 is the monthly 50% Fib that was just lost on the weekly close that triggered this SELL. Above that, $263.34 (weekly EMA20) and $276.36 (weekly 50% Fib) form the zone bulls must recapture to end the correction. The analyst consensus target of $286.79 sits above all near-term resistance.

What legendary investors think

We ran Arm Holdings plc past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
1
Bullish
⚫
1
Neutral
🔴
4
Bearish
The Intrinsic-Value ModelerValuation/DCF🔴 BearishLow

Signal: At 112× forward earnings, the current price implies perpetual earnings growth above 9% from a $2.17 base — even the bull-case DCF yields only $280, barely clearing the $243 stock price. Conviction: What holds conviction in check is the possibility that data-center adoption accelerates sharply enough to justify the premium, though the core smartphone royalty deceleration to 13–15% makes that outcome a stretch.

The GARP OperatorGrowth (GARP)🔴 BearishMed

Signal: The forward P/E of 112× combines with a 31.7% consensus growth rate to produce a PEG of 3.5 — at that multiple, every dollar of earnings disappointment compresses the stock violently. Conviction: Conviction hardens because GAAP net income dropped 42% year-over-year in the latest quarter while the stock still trades above 100× forward earnings, a combination that rarely ends well for fast growers.

The Scuttlebutt Growth InvestorGrowth/Management⚫ NeutralMed

Signal: The 15-point checklist scores 12 out of 15, management doubled the AGI CPU pipeline to $2 billion in 90 days, and every major hyperscaler is now shipping Arm-based silicon — the business itself is as strong as ever. Conviction: The reason I cannot turn bullish is singular: at 112× forward earnings with stock-based compensation consuming 22% of revenue annually, the price embeds zero tolerance for even a minor growth hiccup.

The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed

Signal: Management doubled the AGI CPU pipeline from $1 billion to $2 billion in just 90 days, and hyperscaler adoption is accelerating — this is the steep part of the S-curve where the market consistently underestimates compounding. Conviction: Conviction builds on multiple independent signals: the pipeline doubling, the 46% correction off the all-time high removing speculative froth, and the temporary nature of the memory-cost headwind depressing smartphone royalties.

The Quality RationalistMental Models/Quality🔴 BearishMed

Signal: The business earns a 9 out of 10 on competitive advantage with 97.5% gross margins and an ecosystem that is extraordinarily difficult to displace — yet the $2 billion AI pipeline is a rounding error against a $260 billion market cap. Conviction: The bearish view draws strength from the sheer arithmetic: even a wonderful business cannot compound capital at rates that justify a 112× forward multiple when its cash-cow royalty stream is decelerating and its pivot to chip-making adds capital intensity.

The Forensic SkepticContrarian/Forensic🔴 BearishMed

Signal: Stock-based compensation of $1.15 billion annually exceeds GAAP net income of $1.04 billion, so true cash earnings are negligible once dilution is properly accounted for. Conviction: Conviction firms because the smartphone royalty deceleration to 13–15% is not cyclical — it reflects a maturing end-market that the AI narrative has obscured, and the 21% EPS estimate cut in August is the first crack, not the last.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • All six voices agree the business possesses a genuinely wide moat — a dominant instruction-set architecture with 90%+ mobile share and deep ecosystem lock-in that makes displacement extraordinarily difficult.
  • Everyone acknowledges the AI data-center opportunity is real, with hyperscaler adoption (AWS, Nvidia, Google, Microsoft) providing tangible validation beyond the narrative.
  • All voices recognize the valuation is extreme at 112× forward earnings and 50× sales, leaving zero cushion for execution missteps.
  • Smartphone royalty deceleration (guided to 13–15% from ~20%) is a near-term headwind that every archetype, including the lone bull, must contend with.

The real debate

The question it comes down to: Can the AI data-center revenue ramp fast enough to offset the smartphone royalty deceleration before the 112× multiple compresses, or will the core business slowdown drag the stock down first?

The bottom line

  • Trigger to confirm the breakdown: A weekly close below the EMA50 at $214.44 would signal Stage 4 decline and open a path toward the low analyst target of $125.
  • Trigger to reverse the call: A weekly close above the EMA20 at $263.34 with the MACD histogram turning positive would confirm the correction is over and flip the bearish setup back to neutral.
  • Next catalyst: Q2 FY2027 earnings in late October 2026 — another GAAP net income decline or a lowered AI pipeline figure would likely accelerate multiple compression toward the low-end targets.
  • Royalty growth to monitor: Royalty growth re-accelerating back above 20% would validate the temporary-headwind thesis that underpins the lone bullish voice and would force a reassessment of the bear case.
  • Structural risk further out: A RISC-V design win at any major hyperscaler would strike at the moat itself and require re-evaluating the entire long-term investment thesis from the ground up.

contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in ARM · ARM verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of ARM's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.